Hi-Tech Pharma announced today that the USFDA has granted final approval to the Company's Abbreviated New Drug Application for Ofloxacin otic solution, 0.3%. Hi-Tech's Ofloxacin otic solution is the generic equivalent of Daiichi's Floxin(R) otic solution, 0.3% indicated for the treatment of bacterial infections of the ear.